deltatrials
Unknown NA NCT02592473

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Prostate Artery Embolization Safety and Efficacy: A Pilot Study

Sponsor: Siemens Medical Solutions

Conditions Benign Prostatic Hyperplasia (BPH) Genital Diseases, Male Hyperplasia Lower Urinary Tract Symptoms (LUTS) Male Urogenital Diseases Prostatic Hyperplasia Prostatic Hypertrophy Prostatism
Interventions Embozene Microspheres
Updated 8 times since 2017 Last updated: Apr 15, 2019 Started: Nov 30, 2015 Primary completion: Nov 30, 2021 Completion: Nov 30, 2021

Listed as NCT02592473, this NA trial focuses on Benign Prostatic Hyperplasia (BPH) and Genital Diseases, Male and remains ongoing. Sponsored by Siemens Medical Solutions, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Mar 2022 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Mar 2022 [monthly]

    Recruiting NA

  5. May 2019 — Jan 2021 [monthly]

    Recruiting NA

    Phase: PHASE1 → NA

▶ Show 3 earlier versions

  1. Jun 2018 — May 2019 [monthly]

    Recruiting PHASE1

  2. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  3. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Siemens Medical Solutions
  • University of Virginia
Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Charlottesville, United States